Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Surgical Procedures, Operative × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 65 Breast Neoplasms 51 Rectal Neoplasms 48 Stomach Neoplasms 38 Esophageal Neoplasms 38 Glioblastoma 35 Colorectal Neoplasms 30 Lung Neoplasms 29 Brain Neoplasms 29 Squamous Cell Carcinoma of Head and Neck 23 Neoplasms 23 Pancreatic Neoplasms 22 Glioma 22 Sarcoma 18 Neoplasm Metastasis 18 Astrocytoma 18 Head and Neck Neoplasms 17 Carcinoma, Hepatocellular 16 Esophageal Squamous Cell Carcinoma 15 Recurrence 14 Ovarian Neoplasms 14 Melanoma 13 Gliosarcoma 13 Central Nervous System Neoplasms 13 Colonic Neoplasms 12 Urinary Bladder Neoplasms 11 Adenocarcinoma Of Esophagus 11 Prostatic Neoplasms 10 Oropharyngeal Neoplasms 10 Oligodendroglioma 10

Interventions

pembrolizumab 24 avelumab 19 Nivolumab 18 Ipilimumab 9 Radiotherapy 8 Cyclophosphamide 8 atezolizumab 7 fludarabine 6 cemiplimab 5 aldesleukin 5 Radiation 5 talimogene laherparepvec 4 durvalumab 4 Specimen Handling 4 Interleukin-2 4 Biopsy 4 ALT-803 4 poly ICLC 3 Radiosurgery 3 Magnetic Resonance Spectroscopy 3 Bevacizumab 3 lutetium Lu 177 dotatate 2 fludarabine phosphate 2 domatinostat 2 budigalimab 2 Sirolimus 2 Paclitaxel 2 Interferon-beta 2 Immunoglobulin G 2 Immune Checkpoint Inhibitors 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05253144 2024-05-08

Rational-MCC

University of Birmingham

Phase NA Completed

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡